Jie Xing

530 citations
31 papers · 428 indexed · h-index 12
Topics
Nanoplatforms for cancer theranostics (12 papers)Nanoparticle-Based Drug Delivery (7 papers)Cellular and Composite Structures (5 papers)
Partner nations
ChinaCanadaUnited States

In The Last Decade

Jie Xing

26 papers receiving 421 citations

Peers

Jie Xing
Comparison fields: 5 of 72
  • Biomedical Engineering 244
  • Materials Chemistry 193
  • Molecular Biology 95
  • Biomaterials 83
  • Electronic, Optical and Magnetic Materials 62
Replace Junlie Yao with:
Junlie Yao China
Thomas W. Price United Kingdom
Alana Mauluidy Soehartono Singapore
Xiaoyuan Wang China
Ahmat Khurshid Pakistan
Elizaveta N. Mochalova Russia
Shi Gao China
Suvra S. Laha United States
Jeong Chan Park South Korea
Jie Xing relative to Junlie Yao China Junlie Yao's profile →
Citations per field
00.5×
Junlie Yao · 1×
Citations per year

Countries citing papers authored by Jie Xing

Since Specialization
Citations

This map shows the geographic impact of Jie Xing's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jie Xing with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jie Xing more than expected).

Fields of papers citing papers by Jie Xing

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jie Xing. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jie Xing. The network helps show where Jie Xing may publish in the future.

Co-authorship network of co-authors of Jie Xing

This figure shows the co-authorship network connecting the top 25 collaborators of Jie Xing. A scholar is included among the top collaborators of Jie Xing based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jie Xing. Jie Xing is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 2
2 0
3 0
4 2
5 0
6 6
7 1
8 12
9 1
10 0
11 1
12 5
13 55
14 15
15 6
16 21
17 45
18 91
19 6
20
[The tissue distribution in mice and pharmacokinetics in rabbits of oridonin-solid lipid nanoparticles].
15

About Jie Xing

Jie Xing is a scholar working on General Engineering, Biomaterials and Biomedical Engineering, having authored 31 papers that have together received 428 indexed citations. Recurring topics across this work include Nanoplatforms for cancer theranostics (12 papers), Nanoparticle-Based Drug Delivery (7 papers) and Cellular and Composite Structures (5 papers). The work is most often cited by research in Biomaterials (83 citations), Biomedical Engineering (244 citations) and Biophysics (24 citations). Jie Xing has collaborated with scholars based in China, Canada and United States. Frequent co-authors include Aiguo Wu, Junlie Yao, Chuang LIU, Ozioma Udochukwu Akakuru, Xiawei Xu, Fang Yang, Lijia Luo, Ruifen Zou, Zhe Yu and Madiha Saeed. Their work appears in journals such as ACS Nano, Journal of Applied Physics and ACS Applied Materials & Interfaces.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026